Nurokind-G Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Nurokind-G Tablet
Neuropathic pain relief is provided by the oral medication, CalmaNeu G tablet, a combined formulation. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain sensation. CalmaNeu G should be ingested once daily, ideally before sleep, with or without food, for consistent blood levels. Always adhere to your physician's prescribed dosage and duration. Missed doses should be taken upon recall. Complete the entire course of treatment, regardless of symptom improvement. Abrupt cessation requires prior medical consultation. Commonly reported adverse effects include nausea, peripheral swelling, gait instability, vision blurring, fever, and involuntary eye movements (nystagmus). Drowsiness and dizziness are possible; avoid activities demanding concentration until the medication's effects are known. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose pregnancy, pregnancy planning, or breastfeeding before commencing treatment. While generally compatible with other medications, interactions exist with certain drugs (including antacids and alcohol), potentially increasing adverse reactions.
Uses of Nurokind-G Tablet
Managing neuropathic pain
Major Benefits of Nurokind-G Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Nurokind-G Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Nurokind-G Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Nurokind-G Tablet:
Administer this medication precisely as your physician directs, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nurokind-G Tablets can be consumed with or without food, though consistent timing is recommended.
How Nurokind-G Tablet works:
Nurokind-G tablets contain Gabapentin and Methylcobalamin, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. Methylcobalamin, a B vitamin, supports myelin production, protecting and repairing nerve fibers. This combined action provides relief from the discomfort of nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Nurokind-G tablets and alcohol may result in increased somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Nurokind-G tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Taking Nurokind-G tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, infants should be observed for increased sleepiness or weight gain.
DrivingUNSAFE
Taking Nurokind-G tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Nurokind-G tablets, as dose modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Nurokind-G Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Nurokind-G Tablet :
Should you forget a Nurokind-G Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nurokind-G Tablet
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Neuroscience of the Central Nervous System |